» Articles » PMID: 35304997

Isolated Amyloidosis of the Gastro-intestinal Tract

Overview
Specialty Gastroenterology
Date 2022 Mar 19
PMID 35304997
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloidosis is a very rare condition, which, due to its rarity, is often missed or diagnosed in an advanced stage of the disease, causing significant morbidity and mortality. In this review we describe the existing types of amyloidosis focusing on the gastro-intestinal tract. Amyloidosis occurs when abnormal protein fibrils (amyloid) deposit in the muscularis mucosae. This can cause an array of symptoms ranging from (in order of occurrence): gastro-intestinal bleeding, heartburn, unintentional weight loss, early satiety, constipation, diarrhea, nausea, vomiting and fecal incontinence (1). Treatment is focused on the underlying condition (if any) causing the production and deposition of the abnormal fibrils, in combination of symptomatic treatment.

Citing Articles

Teduglutide in amyloidosis-associated intestinal failure.

Luhn C, Agis H, Hutterer E, Simonitsch-Klupp I, Dawoud C, Stift A Clin Case Rep. 2023; 11(8):e7653.

PMID: 37601424 PMC: 10433832. DOI: 10.1002/ccr3.7653.